Seromucinous Hamartoma of the Nasal Cavity: A Rare Entity Presenting a Diagnostic Challenge in Preoperative Biopsy
Diagnostics · 10.05.2026 · 16 (10) · 1452
DOI: 10.3390/diagnostics16101452 ↗Kurz gefasst
Fallbericht in der Zeitschrift Diagnostics, online erschienen am 10.05.2026. Verfasst von Taimei Egashira und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu 514-8507, Mie, Japan. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Seromucinous hamartoma (SH) is an extremely rare benign glandular lesion arising in the nasal cavity and paranasal sinuses, characterized by proliferation of serous and mucinous glands. Preoperative diagnosis by biopsy is extremely uncommon, making it a diagnostic challenge. We report a case of SH and discuss its diagnostic difficulties and management. Case Presentation: A 52-year-old man presented with right-sided nasal obstruction. A lobulated mass in the posterior right nasal cavity was incidentally detected during transnasal endoscopy. The lesion persisted for one year without reduction. CT, MRI, and biopsy failed to provide a definitive diagnosis. The patient was referred to our department, and endoscopic surgery under general anesthesia was performed. The tumor was removed en bloc. Histopathological examination revealed glandular proliferation of mixed serous and mucinous glands within the subepithelial stroma, consistent with SH.
Discussion
Preoperative diagnosis is difficult due to insufficient biopsy depth and limited recognition of this rare entity. Since the surface epithelium shows no atypia, identification of subepithelial glandular proliferation is essential. Larger and deeper biopsy specimens and communication with pathologists may improve diagnostic yield. Surgical excision is the treatment of choice. As SH often arises in the posterior nasal cavity and is highly vascular, en bloc resection under general anesthesia is recommended.
Conclusions
Recognition of SH is important to improve diagnostic accuracy. Appropriate biopsy strategy and surgical planning based on tumor location are essential.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otorhinolaryngology-Head and Neck Surgery, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu 514-8507, Mie, Japan.
ORCID-Profile: Taimei Egashira, Masayoshi Kobayashi
Zitieren
APA
Egashira, T., Kobayashi, M., & Ishigami, E. (2026). Seromucinous Hamartoma of the Nasal Cavity: A Rare Entity Presenting a Diagnostic Challenge in Preoperative Biopsy. Diagnostics, 16(10), 1452. https://doi.org/10.3390/diagnostics16101452
Vancouver
Egashira T, Kobayashi M, Ishigami E. Seromucinous Hamartoma of the Nasal Cavity: A Rare Entity Presenting a Diagnostic Challenge in Preoperative Biopsy. Diagnostics. 2026;16(10):1452. doi:10.3390/diagnostics16101452
BibTeX
@article{Egashira2026,
author = {Egashira, Taimei and Kobayashi, Masayoshi and Ishigami, Eisuke},
title = {Seromucinous Hamartoma of the Nasal Cavity: A Rare Entity Presenting a Diagnostic Challenge in Preoperative Biopsy},
journal = {Diagnostics},
year = {2026},
volume = {16},
number = {10},
pages = {1452},
doi = {10.3390/diagnostics16101452}
}
EUVIMED